Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Sales (2016 - 2025)

Historic Return on Sales for Niagen Bioscience (NAGE) over the last 17 years, with Q3 2025 value amounting to 0.13%.

  • Niagen Bioscience's Return on Sales rose 600.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year increase of 1500.0%. This contributed to the annual value of 0.09% for FY2024, which is 1400.0% up from last year.
  • Niagen Bioscience's Return on Sales amounted to 0.13% in Q3 2025, which was up 600.0% from 0.12% recorded in Q2 2025.
  • Niagen Bioscience's Return on Sales' 5-year high stood at 0.25% during Q4 2024, with a 5-year trough of 0.51% in Q3 2021.
  • For the 5-year period, Niagen Bioscience's Return on Sales averaged around 0.12%, with its median value being 0.07% (2022).
  • As far as peak fluctuations go, Niagen Bioscience's Return on Sales tumbled by -2100bps in 2021, and later skyrocketed by 3600bps in 2023.
  • Niagen Bioscience's Return on Sales (Quarter) stood at 0.3% in 2021, then skyrocketed by 77bps to 0.07% in 2022, then surged by 108bps to 0.01% in 2023, then surged by 4483bps to 0.25% in 2024, then tumbled by -45bps to 0.13% in 2025.
  • Its Return on Sales was 0.13% in Q3 2025, compared to 0.12% in Q2 2025 and 0.17% in Q1 2025.